10-Q Q3/2020

Company

CytomX Therapeutics, Inc.

Filed

November 5, 2020

Period of Report

September 30, 2020

Accession Number

0001564590-20-051302

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →